Alliancebernstein L.P. Karuna Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $2.22 Million - $4.38 Million	13,787 Added 3.79%	377,155 $119 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $3.39 Million - $4.49 Million	-20,594 Reduced 5.36%	363,368 $61.4 Million
Q2 2023 Aug 15, 2023	SELL	$176.32 - $240.22 $42.7 Million - $58.2 Million	-242,228 Reduced 38.68%	383,962 $83.3 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $6.91 Million - $8.75 Million	42,808 Added 7.34%	626,190 $114 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $11.1 Million - $13.7 Million	57,892 Added 11.02%	583,382 $115 Million
Q3 2022 Nov 15, 2022	BUY	$123.79 - $277.42 $49.4 Million - $111 Million	398,898 Added 315.11%	525,490 $118 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $7.73 Million - $11.8 Million	82,228 Added 185.35%	126,592 $16 Million
Q1 2022 May 13, 2022	BUY	$98.9 - $132.37 $9,890 - $13,237	100 Added 0.23%	44,364 $5.63 Million
Q3 2021 Nov 10, 2021	SELL	$101.2 - $125.87 $215,556 - $268,103	-2,130 Reduced 4.59%	44,264 $5.42 Million
Q2 2021 Jul 30, 2021	BUY	$107.45 - $135.95 $508,238 - $643,043	4,730 Added 11.35%	46,394 $5.29 Million
Q4 2020 Feb 08, 2021	BUY	$75.23 - $109.23 $838,062 - $1.22 Million	11,140 Added 36.5%	41,664 $4.23 Million
Q3 2020 Nov 12, 2020	SELL	$71.31 - $109.74 $175,351 - $269,850	-2,459 Reduced 7.46%	30,524 $2.36 Million
Q2 2020 Aug 13, 2020	BUY	$62.14 - $117.21 $919,672 - $1.73 Million	14,800 Added 81.39%	32,983 $3.68 Million
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $576,492 - $1.11 Million	9,543 Added 110.45%	18,183 $1.31 Million
Q4 2019 Feb 18, 2020	BUY	$11.44 - $123.99 $98,841 - $1.07 Million	8,640 New	8,640 $651,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account